Effect of Paternal Age on Aneuploidy Rates in First Trimester Pregnancy Loss
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Endocrinology of Aging 329 (1989); J
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Erasmus University Digital Repository ARTICLES 37. T. Crook et al., Dev. Neuropsychol. 4, 261 (1986). 344 (1988); ibid. 281, 335 (1989); M. J. West, L. butions and advice, and W. G. M. Janssen, A. P. 38. M. S. Albert, Proc. Natl. Acad. Sci. U.S.A. 93, 13547 Slomianka, H. J. G. Gundersen, Anat. Rec. 231, 482 Leonard, and R. S. Woolley for expert technical as- (1996); iiii and M. B. Moss, in Handbook of (1991); M. J. West, Neurobiol. Aging 14, 275 (1993). sistance. Research in our laboratory was supported Biology of Aging, E. L. Schneider, J. W. Rowe, T. E. 56. We thank C. A. Barnes, C. Bouras, A. H. Gazzaley, by NIH grants AG05138 and AG06647, the Human Johnson, N. J. Holbrook, J. H. Morrison, Eds. (Aca- P. Giannakopoulos, C. V. Mobbs, E. A. Nimchinsky, Brain Project MHDA52145, the Charles A. Dana demic Press, San Diego, CA, ed. 4, 1996), pp. 217– P. R. Rapp, and J. C. Vickers for their crucial contri- Foundation, and the Brookdale Foundation. 233; R. Fama et al., Arch. Neurol. 54, 719 (1997); A. Convit et al., Neurobiol. Aging 18, 131 (1997); C. R. Jack Jr. et al., Neurology 49, 786 (1997). 39. J. W. Rowe and R. L. Kahn, Science 237, 143 (1987). 40. S. L. Vincent, A. Peters, J. Tigges, Anat. Rec. 223, The Endocrinology of Aging 329 (1989); J. Tigges, J. G. Herndon, A. Peters, Neurobiol. Aging 11, 201 (1990); J. Bachevalier et al., ibid. -
Cognition and Steroidogenesis in the Rhesus Macaque
Cognition and Steroidogenesis in the Rhesus Macaque Krystina G Sorwell A DISSERTATION Presented to the Department of Behavioral Neuroscience and the Oregon Health & Science University School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2013 School of Medicine Oregon Health & Science University CERTIFICATE OF APPROVAL This is to certify that the PhD dissertation of Krystina Gerette Sorwell has been approved Henryk Urbanski Mentor/Advisor Steven Kohama Member Kathleen Grant Member Cynthia Bethea Member Deb Finn Member 1 For Lily 2 TABLE OF CONTENTS Acknowledgments ......................................................................................................................................................... 4 List of Figures and Tables ............................................................................................................................................. 7 List of Abbreviations ................................................................................................................................................... 10 Abstract........................................................................................................................................................................ 13 Introduction ................................................................................................................................................................. 15 Part A: Central steroidogenesis and cognition ............................................................................................................ -
Reproductive DHEA-S
Reproductive DHEA-S Analyte Information - 1 - DHEA-S Introduction DHEA-S, DHEA sulfate or dehydroepiandrosterone sulfate, it is a metabolite of dehydroepiandrosterone (DHEA) resulting from the addition of a sulfate group. It is the sulfate form of aromatic C19 steroid with 10,13-dimethyl, 3-hydroxy group and 17-ketone. Its chemical name is 3β-hydroxy-5-androsten-17-one sulfate, its summary formula is C19H28O5S and its molecular weight (Mr) is 368.5 Da. The structural formula of DHEA-S is shown in (Fig.1). Fig.1: Structural formula of DHEA-S Other names used for DHEA-S include: Dehydroisoandrosterone sulfate, (3beta)-3- (sulfooxy), androst-5-en-17-one, 3beta-hydroxy-androst-5-en-17-one hydrogen sulfate, Prasterone sulfate and so on. As DHEA-S is very closely connected with DHEA, both hormones are mentioned together in the following text. Biosynthesis DHEA-S is the major C19 steroid and is a precursor in testosterone and estrogen biosynthesis. DHEA-S originates almost exclusively in the zona reticularis of the adrenal cortex (Fig.2). Some may be produced by the testes, none is produced by the ovaries. The adrenal gland is the sole source of this steroid in women, whereas in men the testes secrete 5% of DHEA-S and 10 – 20% of DHEA. The production of DHEA-S and DHEA is regulated by adrenocorticotropin (ACTH). Corticotropin-releasing hormone (CRH) and, to a lesser extent, arginine vasopressin (AVP) stimulate the release of adrenocorticotropin (ACTH) from the anterior pituitary gland (Fig.3). In turn, ACTH stimulates the adrenal cortex to secrete DHEA and DHEA-S, in addition to cortisol. -
Healthy Aging
HEALTHY AGING Presented by CONTINUING PSYCHOLOGY EDUCATION 8.4 CONTACT HOURS “The ability to prolong life is indeed within our grasp.” Marie-Francoise Schulz-Aellen (1997) Course Objective Learning Objectives The purpose of this course is to provide an Upon completion, the participant will be able to: understanding of the concept of healthy aging. 1. Discuss current biological theories regarding Major topics include current biological theories the causes of aging. of aging, physical factors, prevalent diseases 2. Explain physical factors associated with aging. and health strategies, Baltimore Longitudinal 3. Acknowledge common older adult diseases and Study of Aging, psychological factors, social their recommended preventative measures. factors, long-term care, and the nature of 4. Articulate findings from the Baltimore healthy aging. Longitudinal Study of Aging. 5. Expound upon psychological effects of aging. Accreditation 6. Understand social theories of aging, and the Provider approved by the California Board of value of social support systems. Registered Nursing, Provider # CEP 14008, for 7. Describe prevalent concerns in long-term care. 8.4 Contact Hours. 8. Discuss key characteristics which promote In accordance with the California Code of healthy aging. Regulations, Section 2540.2(b) for licensed vocational nurses and 2592.2(b) for psychiatric technicians, this course is accepted by the Board of Vocational Nursing and Psychiatric Technicians Faculty for 8.4 contact hours of continuing education Neil Eddington, Ph.D. credit. Richard Shuman, MFT Mission Statement Continuing Psychology Education provides the highest quality continuing education designed to fulfill the professional needs and interests of nurses. Resources are offered to improve professional competency, maintain knowledge of the latest advancements, and meet continuing education requirements mandated by the profession. -
Somatopause, Weaknesses of the Therapeutic Approaches and the Cautious Optimism Based on Experimental Ageing Studies with Soy Isoflavones
EXCLI Journal 2018;17:279-301 – ISSN 1611-2156 Received: November 06, 2017, accepted: March 10, 2018, published: March 21, 2018 Review article: SOMATOPAUSE, WEAKNESSES OF THE THERAPEUTIC APPROACHES AND THE CAUTIOUS OPTIMISM BASED ON EXPERIMENTAL AGEING STUDIES WITH SOY ISOFLAVONES Vladimir Ajdžanović1*, Svetlana Trifunović1, Dragana Miljić2, Branka Šošić-Jurjević1, Branko Filipović1, Marko Miler1, Nataša Ristić1, Milica Manojlović-Stojanoski1, Verica Milošević1 1 Department of Cytology, Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia 2 Clinic for Endocrinology, Diabetes and Diseases of Metabolism, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia * Corresponding author: Vladimir Z. Ajdžanović, PhD, Department of Cytology, Institute for Biological Research “Siniša Stanković”, University of Belgrade, Despot Stefan Blvd. 142, 11060 Belgrade, Serbia, Tel: +381-11-2078-321; Fax: +381-11-2761-433, E-mail: [email protected] http://dx.doi.org/10.17179/excli2017-956 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). ABSTRACT The pathological phenomenon of somatopause, noticeable in hypogonadal ageing subjects, is based on the growth hormone (GH) production and secretion decrease along with the fall in GH binding protein and insulin-like growth factor 1 (IGF-1) levels, causing different musculoskeletal, metabolic and mental issues. From the perspective of safety and efficacy, GH treatment is considered to be highly controversial, while some other therapeutic ap- proaches (application of IGF-1, GH secretagogues, gonadal steroids, cholinesterase-inhibitors or various combi- nations) exhibit more or less pronounced weaknesses in this respect. -
Oogenesis [PDF]
Oogenesis Dr Navneet Kumar Professor (Anatomy) K.G.M.U Dr NavneetKumar Professor Anatomy KGMU Lko Oogenesis • Development of ovum (oogenesis) • Maturation of follicle • Fate of ovum and follicle Dr NavneetKumar Professor Anatomy KGMU Lko Dr NavneetKumar Professor Anatomy KGMU Lko Oogenesis • Site – ovary • Duration – 7th week of embryo –primordial germ cells • -3rd month of fetus –oogonium • - two million primary oocyte • -7th month of fetus primary oocyte +primary follicle • - at birth primary oocyte with prophase of • 1st meiotic division • - 40 thousand primary oocyte in adult ovary • - 500 primary oocyte attain maturity • - oogenesis completed after fertilization Dr Navneet Kumar Dr NavneetKumar Professor Professor (Anatomy) Anatomy KGMU Lko K.G.M.U Development of ovum Oogonium(44XX) -In fetal ovary Primary oocyte (44XX) arrest till puberty in prophase of 1st phase meiotic division Secondary oocyte(22X)+Polar body(22X) 1st phase meiotic division completed at ovulation &enter in 2nd phase Ovum(22X)+polarbody(22X) After fertilization Dr NavneetKumar Professor Anatomy KGMU Lko Dr NavneetKumar Professor Anatomy KGMU Lko Dr Navneet Kumar Dr ProfessorNavneetKumar (Anatomy) Professor K.G.M.UAnatomy KGMU Lko Dr NavneetKumar Professor Anatomy KGMU Lko Maturation of follicle Dr NavneetKumar Professor Anatomy KGMU Lko Maturation of follicle Primordial follicle -Follicular cells Primary follicle -Zona pallucida -Granulosa cells Secondary follicle Antrum developed Ovarian /Graafian follicle - Theca interna &externa -Membrana granulosa -Antrial -
Testosterone Deficiency in Men with Heart Failure: Pathophysiology and Its Clinical, Prognostic and Therapeutic Implications
Kardiologia Polska 2014; 72, 5: 403–409; DOI: 10.5603/KP.a2014.0025 ISSN 0022–9032 ARTYKUŁ SPECJALNY / STATE-OF-THE-ART REVIEW Testosterone deficiency in men with heart failure: pathophysiology and its clinical, prognostic and therapeutic implications Ewa A. Jankowska1, 2, 3, Michał Tkaczyszyn1, Elżbieta Kalicińska2, 4, Waldemar Banasiak2, Piotr Ponikowski2, 4 1Laboratory for Applied Research on Cardiovascular System, Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland 2Cardiology Department, Centre for Heart Diseases, Military Hospital, Wroclaw, Poland 3Institute of Anthropology, Polish Academy of Sciences, Wroclaw, Poland 4Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland HEART FAILURE: According to the data from the European Society of Cardio A CARDIOGERIATRIC SYNDROME logy (ESC) HFPilot registry [15], annual rehospitalisation Heart failure (HF) is a disease syndrome cha rate and mortality among outpatients with chronic HF has racterised by large incidence and prevalence, been estimated at 31.9% and 7.2%, respectively. Thus, new which has been estimated in the developed therapeutic approaches are needed to reverse these adverse countries at 5–10/1000 persons per year epidemiological trends. In the recent years, this search for and 1–2%, respectively [1], with a clear rise new therapies for HF has focused on pathogenetic concepts of these indices with age [2–4]. In the Bri related to noncardiac disturbances and abnormalities in HF tish Hillingdon study [2], the incidence of [16, 17]. In the current research on the pathophysiology and HF among subjects aged 25–34 years was natural history of HF, attention has been paid to renal dysfunc only 0.02/1000 persons per year, rising to tion [18–20], hepatic dysfunction [21, 22], immune activation 11.6/1000 persons per years among subjects [23], autonomic sympathetic/parasympathetic imbalance [24], aged ≥ 85 years. -
Adrenopause Andropause Growth Hormone Somatopause
All “HRT” is not Alike! The Necessity and Safety of Menopause is a hormone-deficiency state with known deleterious Bioidentical Sex-Steroid Restoration consequences for quality of life and health. in Menopause Estradiol-progesterone-testosterone (EPT) replacement for menopause is medically necessary. Estradiol replacement is safe when transdermal and accompanied Henry Lindner, MD by sufficient progesterone and testosterone. Hormonerestoration.com Bioidentical EPT therapy does not have the cardiovascular or breast cancer risks seen with PremPro . This presentation is available on the CD, handout How to provide EPT therapy to menopausal women Adrenopause Not Just “Sex Hormones” DHEA DHEA-S Converted into estradiol and testosterone within tissues Estradiol, progesterone, and testosterone are required for the growth, function and maintenance of all tissues in both sexes! Maintain brain function and health—vital neurosteroids Maintain tissue health/strength: skin, hair, bone, muscle, heart Improve insulin sensitivity: belly fat, risk of diabetes Reduce blood pressure: improve endothelial function Prevent atherosclerosis: reduce risk of MI, stroke What about the loss of hormones with aging? J Clin Endocrinol Metab. 1997 Aug;82(8):2396-402 Andropause Somatopause Testosterone in Men Growth Hormone Baltimore Longitudinal Study of Aging (BLSA). Harman et al., 2001 Clinical Chemistry 48, No. 12, 2002 1 Thyropause Menopause 8000 Men Women Testosterone Progesterone 7000 average 6000 5000 pg/ml Estradiol Estradiol T Endocr Rev. 1995 HP response to low T4 (2.7-3.2g/dL) Dec;16(6):686-715 4000 25-55 pg/ml 0-20 pg/ml 120 P 100 80% 3000 80 E decline 2000 60 TSH 40 1000 20 0 Carle, Thyroid. -
Progression from Meiosis I to Meiosis II in Xenopus Oocytes Requires De
Proc. Natl. Acad. Sci. USA Vol. 88, pp. 5794-5798, July 1991 Biochemistry Progression from meiosis I to meiosis II in Xenopus oocytes requires de novo translation of the mosxe protooncogene (cell cycle/protein kinase/maturation-promoting factor/germinal vesicle breakdown) JOHN P. KANKI* AND DANIEL J. DONOGHUEt Department of Chemistry, Division of Biochemistry and Center for Molecular Genetics, University of California at San Diego, La Jolla, CA 92093-0322 Communicated by Russell F. Doolittle, March 22, 1991 ABSTRACT The meiotic maturation of Xenopus oocytes controlling entry into and exit from M phase (for reviews, see exhibits an early requirement for expression of the mosxe refs. 17-19). protooncogene. The mosxc protein has also been shown to be a In Xenopus, protein synthesis is required for the initiation component of cytostatic factor (CSF), which is responsible for of meiosis I and also meiosis II (4, 20), even though stage VI arrest at metaphase ofmeiosis II. In this study, we have assayed oocytes already contain both p34cdc2 and cyclin (12, 21). the appearance of CSF activity in oocytes induced to mature These proteins are partially complexed in an inactive form of either by progesterone treatment or by overexpression ofmosxe. MPF (preMPF) that appears to be normally inhibited by a Progesterone-stimulated oocytes did not exhibit CSF activity protein phosphatase activity called "INH" (22, 23). These until 30-60 min after germinal vesicle breakdown (GVBD). observations indicate a translational requirement, both for Both the appearance of CSF activity and the progression from the initiation of maturation and for progression to meiosis II, meiosis I to meiosis II were inhibited by microinjection of mos"e for a regulatory factor(s) other than cyclin. -
Oocyte Or Embryo Donation to Women of Advanced Reproductive Age: an Ethics Committee Opinion
ASRM PAGES Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion Ethics Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama Advanced reproductive age (ARA) is a risk factor for female infertility, pregnancy loss, fetal anomalies, stillbirth, and obstetric com- plications. Oocyte donation reverses the age-related decline in implantation and birth rates of women in their 40s and 50s and restores pregnancy potential beyond menopause. However, obstetrical complications in older patients remain high, particularly related to oper- ative delivery and hypertensive and cardiovascular risks. Physicians should perform a thorough medical evaluation designed to assess the physical fitness of a patient for pregnancy before deciding to attempt transfer of embryos to any woman of advanced reproductive age (>45 years). Embryo transfer should be strongly discouraged or denied to women of ARA with underlying conditions that increase or exacerbate obstetrical risks. Because of concerns related to the high-risk nature of pregnancy, as well as longevity, treatment of women over the age of 55 should generally be discouraged. This statement replaces the earlier ASRM Ethics Committee document of the same name, last published in 2013 (Fertil Steril 2013;100:337–40). (Fertil SterilÒ 2016;106:e3–7. Ó2016 by American Society for Reproductive Medicine.) Key Words: Ethics, third-party reproduction, complications, pregnancy, parenting Discuss: You can discuss -
Female and Male Gametogenesis 3 Nina Desai , Jennifer Ludgin , Rakesh Sharma , Raj Kumar Anirudh , and Ashok Agarwal
Female and Male Gametogenesis 3 Nina Desai , Jennifer Ludgin , Rakesh Sharma , Raj Kumar Anirudh , and Ashok Agarwal intimately part of the endocrine responsibility of the ovary. Introduction If there are no gametes, then hormone production is drastically curtailed. Depletion of oocytes implies depletion of the major Oogenesis is an area that has long been of interest in medicine, hormones of the ovary. In the male this is not the case. as well as biology, economics, sociology, and public policy. Androgen production will proceed normally without a single Almost four centuries ago, the English physician William spermatozoa in the testes. Harvey (1578–1657) wrote ex ovo omnia —“all that is alive This chapter presents basic aspects of human ovarian comes from the egg.” follicle growth, oogenesis, and some of the regulatory mech- During a women’s reproductive life span only 300–400 of anisms involved [ 1 ] , as well as some of the basic structural the nearly 1–2 million oocytes present in her ovaries at birth morphology of the testes and the process of development to are ovulated. The process of oogenesis begins with migra- obtain mature spermatozoa. tory primordial germ cells (PGCs). It results in the produc- tion of meiotically competent oocytes containing the correct genetic material, proteins, mRNA transcripts, and organ- Structure of the Ovary elles that are necessary to create a viable embryo. This is a tightly controlled process involving not only ovarian para- The ovary, which contains the germ cells, is the main repro- crine factors but also signaling from gonadotropins secreted ductive organ in the female. -
Fertilization: a Sperm's Journey to and Interaction with the Oocyte
Fertilization: a sperm’s journey to and interaction with the oocyte Masahito Ikawa, … , Adam M. Benham, Masaru Okabe J Clin Invest. 2010;120(4):984-994. https://doi.org/10.1172/JCI41585. Review Series Mammalian fertilization comprises sperm migration through the female reproductive tract, biochemical and morphological changes to sperm, and sperm-egg interaction in the oviduct. Recent gene knockout approaches in mice have revealed that many factors previously considered important for fertilization are largely dispensable, or if they are essential, they have an unexpected function. These results indicate that what has been observed in in vitro fertilization (IVF) differs significantly from what occurs during “physiological” fertilization. This Review focuses on the advantages of studying fertilization using gene-manipulated animals and highlights an emerging molecular mechanism of mammalian fertilization. Find the latest version: http://jci.me/41585-pdf Review series Fertilization: a sperm’s journey to and interaction with the oocyte Masahito Ikawa,1 Naokazu Inoue,1 Adam M. Benham,1,2 and Masaru Okabe1 1Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. 2School of Biological and Biomedical Sciences, Durham University, United Kingdom. Mammalian fertilization comprises sperm migration through the female reproductive tract, biochemical and mor- phological changes to sperm, and sperm-egg interaction in the oviduct. Recent gene knockout approaches in mice have revealed that many factors previously considered important for fertilization are largely dispensable, or if they are essential, they have an unexpected function. These results indicate that what has been observed in in vitro fer- tilization (IVF) differs significantly from what occurs during “physiological” fertilization. This Review focuses on the advantages of studying fertilization using gene-manipulated animals and highlights an emerging molecular mechanism of mammalian fertilization.